Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Ischemia

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Ischemia in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonoki, H1
Uchida, Y1
Tomaru, T1
Sugimoto, T1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Ischemia

ArticleYear
[The effects of TMB-8, an intracellular Ca2+ antagonist, on impaired left ventricular relaxation by global ischemia in dog].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 91, Issue:3

    Topics: Animals; Calcium Channel Blockers; Calmodulin; Dogs; Gallic Acid; Heart Rate; Heart Ventricles; Hemo

1988